Litcius/Paper detail

Claudin 18.2 as a novel therapeutic target

Izuma Nakayama, Changsong Qi, Yang Chen, Yoshiaki Nakamura, Lin Shen, Kohei Shitara

2024Nature Reviews Clinical Oncology164 citationsDOI

Topics & Concepts

ClaudinMonoclonal antibodyCancerAntibodyCancer researchMedicineAntibody-drug conjugateBystander effectChimeric antigen receptorTargeted therapyTight junctionOncologyImmunologyImmunotherapyInternal medicineBiologyCell biologyBarrier Structure and Function StudiesCancer-related molecular mechanisms researchPancreatic and Hepatic Oncology Research
Claudin 18.2 as a novel therapeutic target | Litcius